[breadcrumb_custom]

Tag: PTGX stock

Finance

Are Protagonist Therapeutics Inc. (NASDAQ:PTGX) Prospects Worsening?

Protagonist Therapeutics Inc. (NASDAQ:PTGX) shares traded higher over the last trading session, gaining 9.33% on 06/16/21. The shares fell to a low of $39.50 before

Companies

Analyst’s Sets Protagonist Therapeutics Inc. (NASDAQ:PTGX) New Target at $39.57: PTGX is Now On A Buy List

Protagonist Therapeutics Inc. (NASDAQ:PTGX) has a beta of 1.55. The stock’s Relative Strength Index (RSI) is 53.64, with weekly volatility at 5.86% and ATR at

Companies

Protagonist Therapeutics Inc. (PTGX) move up 0.92% this morning: PTGX Price Rally Looks Real

Protagonist Therapeutics Inc. (NASDAQ:PTGX) shares traded higher over the last trading session, gaining 0.92% on 05/27/21. The shares fell to a low of $33.59 before

Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.

Quick Links

About Us

Our Team

Disclaimer

Tag: PTGX stock

Are Protagonist Therapeutics Inc. (NASDAQ:PTGX) Prospects Worsening?

Analyst’s Sets Protagonist Therapeutics Inc. (NASDAQ:PTGX) New Target at $39.57: PTGX is Now On A Buy List

Protagonist Therapeutics Inc. (PTGX) move up 0.92% this morning: PTGX Price Rally Looks Real

Quick Links

Categories